ePresciption as an Element of Interprofessional Pathways for Continuous Medication Safety Management – Phase 2

ePresciption as an Element of Interprofessional Pathways for Continuous Medication Safety Management – Phase 2 - eRIKA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035030

Enrollment

3528

Registered

2025-02-10

Start date

2025-04-11

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients regularly taking = 3 drugs

Interventions

Group 1: Implementation of the eRIKA intervention to improve medication safety management in medical practices and pharmacies. The main components are: 1) Use of claims data from health insurers to i

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Insured with one of the participating health insurances Polypharmacy (= 3 long-term medication use)

Exclusion criteria

Exclusion criteria: Not insured with one of the participating health insurances No polypharmacy (< 3 long-term medication use)

Design outcomes

Primary

Measure	Time frame
Incidence of hospitalisation or death within three months after prescription	—

Secondary

Measure	Time frame
Incidence of diagnoses and inpatient and outpatient services utilisation induced by adverse drug events (ADE) Incidence of potentially inappropriate medication (PIM) events Process-related outputs/outcomes as an indicator for intervention fidelity Implementation and acceptance of intervention by stakeholders Utilization of healthcare services and cost (-effectiveness) Cost-effectiveness of the intervention under routine care	—

Measure

Time frame

Incidence of diagnoses and inpatient and outpatient services utilisation induced by adverse drug events (ADE) Incidence of potentially inappropriate medication (PIM) events Process-related outputs/outcomes as an indicator for intervention fidelity Implementation and acceptance of intervention by stakeholders Utilization of healthcare services and cost (-effectiveness) Cost-effectiveness of the intervention under routine care

—

Countries

Germany

Contacts

Public ContactLara Düvel

BARMER Abteilung Digitale Versorgung / Prävention

Lara.Duevel@barmer.de+49 800 333004 99-3267

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026